Related Experiment Video
Updated: Aug 18, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pseudomonal infection in cystic fibrosis: the battle continues
1Department of Cystic Fibrosis Royal Brompton Hospital London SW3 6NP, UK. sarah.elkin@st-marys.nhs.uk
Insights
Pseudomonas aeruginosa lung infections are a primary cause of death in cystic fibrosis patients. Understanding bacterial colonization and biofilm growth offers new therapeutic strategies.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Genetics
Background:
- Pseudomonas aeruginosa lung infection is a leading cause of morbidity and mortality in cystic fibrosis (CF) patients.
- Infection, often starting in childhood, leads to respiratory failure and death.
- The bacteria trigger chronic inflammation, damaging airways and causing progressive lung function loss.
Purpose of the Study:
- To review the pathophysiology of Pseudomonas aeruginosa infection in cystic fibrosis airways.
- To explore bacterial colonization mechanisms, persistence, and biofilm formation.
- To discuss current treatments and novel therapeutic approaches.
Main Methods:
- Literature review of Pseudomonas aeruginosa infection in cystic fibrosis.
- Analysis of bacterial colonization, persistence, and biofilm growth mechanisms.
- Summary of existing and emerging therapeutic strategies.
Main Results:
- Significant advances in understanding CF pathophysiology have been made.
- Mechanisms of Pseudomonas aeruginosa colonization and persistence in CF airways are complex.
- Biofilm formation is a key factor in chronic infection and treatment resistance.
Conclusions:
- Improved understanding of Pseudomonas aeruginosa infection in CF aids new therapy development.
- Targeting colonization, persistence, and biofilm may offer novel treatment avenues.
- Further research is needed to develop effective therapies against this pathogen in CF.
Abstract:
Pseudomonas aeruginosa lung infection is the major cause of morbidity and mortality in patients with cystic fibrosis. Infection usually begins in childhood and is responsible for respiratory failure and death in most patients with cystic fibrosis. The organism triggers an exuberant chronic inflammatory reaction which damages the airways and leads to progressive loss of lung function. Over the last decade significant advances have been made in the understanding of the pathophysiology of cystic fibrosis airways disease. These should assist the development of new and better therapies to treat this pathogen. This review provides an overview of pseudomonal infection in cystic fibrosis, including mechanisms by which the bacteria may colonize the cystic fibrosis airway, persistence of pseudomonal infection and the biofilm mode of growth. Available treatments and possible novel approaches to therapy will be discussed.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Cryptococcal Meningitis
Clinical Significance of Antibiotic Resistance

